-
A.forall Announces First US Launch with Coveted Competitive Generic Therapy (CGT) Exclusivity of Tromethamine Injection 18GM/500mL
30 Jan 2025 16:27 GMT
… #47;500mL marketed by Hospira Inc, a Pfizer company … another instance where Competitive Generic Therapy (CGT) eligibility … we develop value-added generic pharmaceuticals, solve product … acquisition, and commercialization of generic prescription drugs for the …
-
Human medicines European public assessment report (EPAR): Voriconazole Hikma (previously Voriconazole Hospira), voriconazole, Date of authorisation: 27/05/2015, Revision: 14, Status: Authorised
23 Aug 2024 15:04 GMT
Voriconazole Hikma is an antifungal medicine used for the treatment of adults and children over the age of two years who have the following infections caused by a fungus:
invasive aspergillosis (a type of fungal infection due to Aspergillus);
candidaemia ( …
-
Erythropoietin Drugs Market to Reach $14.41 Bn by 2032, Fueled by 5.7% CAGR: Johnson & Johnson, Amgen, Roche, Hospira
08 Jul 2024 12:58 GMT
… is characterized by presence of generic epoetin products. Asia-Pacific and … & Johnson
Amgen Inc.,
Roche, Hospira Inc.
Biocon
LG Life Sciences …
-
Astellas’ generic Myrbetriq defence knocked back again
22 Apr 2024 09:45 GMT
… a report saying that Indian generic drugmakers Lupin Labs and Zydus … hit to its revenues from generic competition in the coming years … to stop Pfizer’s generic medicines unit Hospira from launching a copycat …
-
US Generic Drug Market 2024: A Valuation of US$ 90.4 Billion Predicted by 2032 | IMARC Group
30 Jan 2024 12:56 GMT
… the availability and affordability of generic medications, benefiting both consumers … bolstering the growth of the generic drug market.
• Rising Healthcare …
• Dr Reddy’s
• Hospira (Pfizer)
US Generic Injectables Market Report Segmentation …
-
US Generic Drug Market Report 2023: Sector is Expected to Reach $110.7 Billion by 2028 at a CAGR of 4.12% - ResearchAndMarkets.com
15 May 2023 12:28 GMT
… Pharmaceuticals
Dr Reddy's
Hospira (Pfizer)
Thermo Fisher Scientific Inc … testing.
Additionally, the introduction of generic medicines has helped in sustaining … manufacturers. Furthermore, to enhance the generic-drug development and approval process …
-
Generic Sterile Injectable Market [+CAGR of 11.6%] | Driven by the growing demand for Online Pharmacies, 2023-2033
15 Mar 2023 06:04 GMT
… are also driving demand for generic sterile injectables.
Key Statistics:
According … Inc, Fresenius Kabi, Pfizer/Hospira, Novartis/Sandoz, Teva, Hikma … requirements for the approval of generic sterile injectables.
Opportunities:
The key …
-
2022 First Generic Drug Approvals
03 Mar 2023 17:52 GMT
107
215924
Dichlorphenamide Tablets USP, 50 mg
Torrent Pharma Inc.
Keveyis (Dichlorphenamide) Tablets
12/29/2022
For the treatment of primary hyperkalemic periodic paralysis, primary hypokalemic periodic paralysis, and related variants
106
216145
…
-
Alembic Pharma gets USFDA approval to market generic cancer drug
01 Mar 2023 15:48 GMT
… health regulator to market a generic breast cancer drug.
The company … product is therapeutically equivalent to Hospira Inc's drug.
Docetaxel …
-
Alembic Pharma gets USFDA nod to market generic cancer drug
01 Mar 2023 10:17 GMT
… health regulator to market a generic breast cancer drug. The company … product is therapeutically equivalent to Hospira Inc's drug.
Docetaxel …
About
© 1995-2025